Implementing de-implementation strategies is often harder than starting new treatments. EHR deprescribing nudges are clinical decision support (CDS) tools designed to reduce low-value care, such as overtreatment of diabetes in older adults. However, a recent large-scale trial across a major health system found that these automated alerts frequently failed to change clinician behavior. While the concept of computerized reminders seems efficient, the reality of clinical practice presents complex hurdles that technology alone cannot solve.

Understanding the Role of EHR Deprescribing Nudges

Electronic health record (EHR) systems utilize EHR deprescribing nudges to align treatment with Choosing Wisely guidelines. In the context of geriatrics, these guidelines often recommend relaxing glycemic targets for older patients with Type 2 diabetes to prevent hypoglycemia. Despite the theoretical benefits, a process evaluation of over 66,000 alerts revealed that providers rarely engaged with the nudges. When they did, their feedback often pointed toward systematic failures in the digital intervention's design. This highlights that simply firing an alert is insufficient if the context of the clinical encounter is ignored.

Three Critical Barriers to Nudge Effectiveness

Thematic analysis of clinician comments identified three primary reasons why EHR deprescribing nudges were ignored or rejected. First, many providers expressed direct disagreement with the underlying guidelines. They often perceived the risk of overtreatment as low or felt the patient's current stability was more important than aggressive dose reduction. Second, workflow misalignment proved to be a significant obstacle. Clinicians noted that alerts often fired for the wrong provider or at an inappropriate stage of the patient visit. Finally, patient preferences and resistance to changing long-standing medication regimens created a social barrier that digital tools could not navigate.

Improving Clinical Decision Support in India

For practitioners in India, where the geriatric diabetic population is growing rapidly, these findings are highly relevant. Local guidelines from the Research Society for the Study of Diabetes in India (RSSDI) also advocate for individualized HbA1c targets. Therefore, future EHR systems must move beyond generic alerts. Designers should focus on enhancing guideline explainability to build trust among clinicians. Additionally, tools must be better integrated into the specific roles of the healthcare team. By addressing these human and organizational factors, healthcare systems can transform EHR deprescribing nudges from annoying interruptions into valuable clinical assets.

Frequently Asked Questions

Why are clinicians often resistant to EHR-based deprescribing?

Clinicians often resist these nudges due to perceived misalignment with their specific workflow, disagreement with generic clinical guidelines for individual patients, and the difficulty of managing patient expectations regarding medication changes.

Can behavioral science improve the success of EHR alerts?

Yes, strategies such as "precommitment" or more personalized, timely reminders have shown some promise in increasing engagement, though they still face barriers like "alert fatigue" and patient reluctance.

What should developers focus on to make CDS more effective?

Developers should focus on improving the explainability of guidelines within the alert, ensuring the alert reaches the most relevant provider, and incorporating patient-centered communication tools into the nudge.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.

References

Viswanadham RVN et al. Provider comments reveal barriers to EHR nudge effectiveness: process evaluation of a null deprescribing trial. Implement Sci Commun. 2026 Jun 06. doi: 10.1186/s43058-026-00983-2. PMID: 42251456.